Molecular determinants of S100B oligomer formation

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Thulin, Eva ^a   Kesvatera, Tõnu ^b   Linse, Sara ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; CALCIUM ION; DIMER; DISULFIDE; IMIDAZOLE; MONOMER; PROTEIN P53; PROTEIN S100B; PROTON; TETRAMER; BIOPOLYMER; CALCIUM; IMIDAZOLE DERIVATIVE; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; SODIUM CHLORIDE; ZINC;

ARTICLE; BINDING AFFINITY; CHEMICAL BOND; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; GEL FILTRATION; LIGHT SCATTERING; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION POTENTIAL; PH; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PURIFICATION; STOICHIOMETRY; THERMODYNAMICS; AMINO ACID SEQUENCE; CHEMISTRY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION;

AMINO ACID SEQUENCE; BIOPOLYMERS; CALCIUM; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; OXIDATION-REDUCTION; S100 PROTEINS; SODIUM CHLORIDE; ZINC;

EID: 79952777365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014768     Document Type: Article

References (35)

1. Donato R, (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The international journal of biochemistry and cell biology 33: 637-668.
2. Donato R, (2003) Intracellular and extracellular roles of S100 proteins. Microscopy Research and Technique 60: 540-551.
3. Heizmann CW, Fritz G, Schäfer BW, (2002) S100 proteins: structure, functions and pathology. Front Biosci. 7: d1356-1368.
4. Rothermundt M, Peters M, Prehn JHM, Arolt V, (2003) S100B in brain damage and neurodegeneration. Microscopy Research and Technique 60: 614-632.
5. Schäfer BW, Heizmann CW, (1996) The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-40.
6. Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, et al. (2001) S100B expression in and effects on microglia. Glia 33: 131-42.
7. Businaro R, Leone S, Fabrizi C, Sorci G, Donato R, et al. (2006) S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res 83: 897-906.
8. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, et al. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105.
9. Riuzzi F, Sorci G, Donato R, (2006) S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J Cell Physiol 207: 461-470.
10. Van Eldik LJ, Wainwright MS, (2003) The Janus face of glial-derived S100B: Beneficial and detrimental functions in the brain. Restorative Neurology and Neuroscience 21: 97-108.
11. Jönsson H, (2003) S100B and cardiac surgery: possibilities and limitations. Restorative Neurology and Neuroscience 21: 151-157.
12. Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ, (2001) Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int. 39: 409-413.
13. Harpio R, Einarsson R, (2004) S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clinical Biochemistry 37: 512-518.
14. Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW, (2005) S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J Neurochem 92: 546-553.
15. Lin J, Blake M, Tang C, Zimmer D, Rustandi RR, et al. (2001) Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J Biol Chem 276: 35037-35041.
16. Lin J, Yang Q, Yan Z, Markowitz J, Wilder PT, et al. (2004) Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J Biol Chem 279: 34071-34077.
17. Smith SP, Barber KR, Dunn SD, Shaw GS, (1996) Structural influence o cation binding to recombinant human brain S100b: evidence for calcium-induced exposure of a hydrophobic surface. Biochemitry 35: 8805-8814.
18. Kilby PM, Van Eldik LJ, Roberts GC, (1997) Identification of the binding site on S100B protein for the actin capping protein CapZ. Protein Sci 6: 2494-2503.
19. Rustandi RR, Drohat AC, Baldisseri DM, Wilder PT, Weber DJ, (1998) The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53. Biochemistry 37: 1951-1960.
20. Ferguson PL, Shaw GS, (2004) Human S100B protein interacts with Escehrichia coli dicision protein FtsZ in a calcium-sensitive manner. J Biol Chem 278: 18806-18813.
21. Markowitz J, Rustandi RR, Varney KM, Wilder PT, Udan R, et al. (2005) Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53. Biochemistry 44: 7305-7314.
22. Wilder PT, Baldisseri DM, Udan R, Vallely KM, Weber DJ, (2003) Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Biochemistry 42: 13410-13421.
23. Drohat AC, Amburgey JC, Abildgaard F, Starich MR, Baldisseri D, et al. (1996) Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy. Biochemistry 35: 11577-11588.
24. Drohat AC, Baldisseri DM, Rustandi RR, Weber DJ, (1998) Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37: 2729-2740.
25. Kilby PM, Van Eldik LJ, Roberts GC, (1996) The solution structure of the bovine S100B protein dimer in the calcium-free state. Structure 4: 1041-1052.
26. Smith SP, Shaw GS, (1998) A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure 6: 211-222.
27. Wilder PT, Varney KM, Weiss MB, Gitti RK, Weber DJ, (2005) Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry 44: 5690-5702.
28. Inman KG, Tang R, Rustandi RR, Miller KE, Baldisseri DM, et al. (2002) Solution NMR structure of S100B bound to the high affinity target peptide TRTK-12. J Mol Biol 324: 1003-1014.
29. 2+-s100B-TRTK-12 complex. J Biol Chem 278: 6251-6257.
30. Rustandi RR, Baldisseri DM, Weber DJ, (2000) Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol. 7: 570-574.
31. Drohat AC, Nenortas E, Beckett D, Weber DJ, (1997) Oligomerization state of S100B at nanomolar concentration determined by large-zone analytical gel filtration chromatography. Protein Sci. 6: 1577-1582.
32. Håkansson M, Fast J, Svensson LA, Linse S, (2001) An extended hydrophobic core induces EF-hand swapping. Protein Science 10: 927-933.
33. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, et al. (2007) Structural and functional insight into RAGE activation by multimeric S100B. EMBO J 26: 3868-3878.
34. Laan W, Gauden M, Yeremenko S, van Grondelle R, Kennis JTM, et al. (2006) On the mechanism of activation of the BLUF domain of AppA. Biochemistry 45: 51-60.
35. 2+-binding constants of proteins and presentation of the CaLigator software. Analytical Biochemistry 305: 195-205.